NASDAQ: UNCY - Unicycive Therapeutics, Inc.

Yield per half year: +36.9%
Dividend yield: 0.00%
Sector: Healthcare

Share chart Unicycive Therapeutics, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About Unicycive Therapeutics, Inc.

Unicycive Therapeutics, Inc., биотехнологическая компания, занимается разработкой новых методов лечения заболеваний почек в Соединенных Штатах. Разрабатывается Реназорб для лечения гиперфосфатемии у больных с хронической болезнью почек, находящихся на диализе; и UNI 494, который проходит первую фазу клинических испытаний для лечения острой почечной недостаточности. Компания была зарегистрирована в 2016 году и базируется в Лос-Альтосе, Калифорния.

Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

IPO date 2021-07-12
ISIN US90466Y1038
Industry Biotechnology
Sector Health Care
Валюта usd
Валюта отчета usd
Сайт https://unicycive.com
Цена ао 0.619
Change price per day: -0.073% (0.548)
Change price per week: +18.79% (0.461)
Change price per month: -5.91% (0.582)
Change price per 3 month: -20.21% (0.6863)
Change price per half year: +36.9% (0.4)
Change price per year: -51.96% (1.14)
Change price per 3 year: -55.11% (1.22)
Change price per year to date: -16.78% (0.658)
All parameters

Underestimation

Title Value Grade
P/S 21.09 1
P/BV -3.74 0
P/E 0 0
EV/EBITDA -0.2608 0
Total: 3.75

Efficiency

Title Value Grade
ROA, % -215.24 0
ROE, % 801.89 10
Total: 3.33

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA -0.0396 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % -29.02 0
Yield Ebitda, % 1408.9 10
Yield EPS, % 709.82 10
Total: 8
More

Institutions Volume Share, %
RA Capital Management, L.P. 3470688 9.99
Nantahala Capital Management, LLC 3470541 9.99
Vivo Capital, LLC 3470152 9.98
BVF Inc. 3413563 9.82
Vanguard Group Inc 115057 0.33
Goldman Sachs Group Inc 93233 0.27
Geode Capital Management, LLC 52399 0.15
State Street Corporation 35036 0.1
CapTrust Financial Advisors 18800 0.05
Tandem Capital Management Corporation 15500 0.04



Head Job title Payment Year of birth
Dr. Shalabh K. Gupta M.D., MPA Founder, Chairman, CEO & President 1.46M 1973 (52 years)
Dr. Pramod Gupta Ph.D. Executive Vice President of Pharmaceutical & Business Operations 779.18k 1960 (65 years)
Mr. Douglas Jermasek M.B.A. Executive Vice President of Corporate Strategy 430.81k 1962 (63 years)
Mr. John W. Townsend CPA Chief Financial Officer 197.86k 1962 (63 years)

Address: United States, Los Altos. CA, 4300 El Camino Real - open in Google maps, open in Yandex maps
Website: https://unicycive.com